The tumoricidal activity of salmonella and its role in treating cancers

Cancer Therapy

Volumn 9, Issue , 2013, Pages 10-23

  Abdulamir, Ahmed Sahib ^a,b   Hafidh, R R ^a,c   Abu Bakar, F ^a  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^b AL NAHRAIN UNIVERSITY   (Iraq)

^c UNIVERSITY OF BAGHDAD   (Iraq)

Author keywords

Cytokines; Dendritic cells; Exogenous DNA; Internalization; Peripheral blood mononuclear cells

Indexed keywords

ANTINEOPLASTIC AGENT; APOPTIN; BACTERIAL VECTOR; CHEMOKINE; CISPLATIN; CYTOKINE; DNA VACCINE; FAS LIGAND; FLUOROURACIL; ONCOLYTIC BACTERIA; PRODRUG; PROSTATE SPECIFIC ANTIGEN; RECOMBINANT TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; SALMONELLOSIS VACCINE; SMALL INTERFERING RNA; TUMOR ANTIGEN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ANTISENSE THERAPY; APOPTOSIS; BACTERIAL VIRULENCE; BREAST ADENOCARCINOMA; CANCER GENE THERAPY; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CANCER THERAPY; COLON CANCER; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG TARGETING; HUMAN; INNATE IMMUNITY; INTRACELLULAR TRANSPORT; LIVER CELL CARCINOMA; LOW DRUG DOSE; LUNG METASTASIS; LUNG TUMOR; MELANOMA; MONOTHERAPY; NONHUMAN; PANCREAS CANCER; PROSTATE CANCER; PROSTATE TUMOR; REVIEW; SALMONELLA; SALMONELLA ENTERICA; SALMONELLA TYPHIMURIUM; TUMOR MICROENVIRONMENT; TYPE III SECRETION SYSTEM; UNSPECIFIED SIDE EFFECT;

EID: 84876034849     PISSN: 15439135     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (90)

1. Agrawal, N., Bettegowda, C., Cheong, I., et al. (2004) Bacteriolytic therapy can generate a potent immune response against experimental tumors. Proc. Natl. Acad. Sci. USA 101, 15172-15177.
2. Akaza H (1995). BCG treatment of existing Ta, T1 tumours or carcinoma in situ of the bladder. Eur Urol 27(Suppl 1):9-12.
3. al-Ramadi, B. K., Al-Dhaheri, M. H., Mustafa, N., et al. (2001) Influence of vectorencoded cytokines on anti-Salmonella immunity: divergent effects of interleukin-2 and tumor necrosis factor alpha. Infect. Immun. 69, 3980-3988.
4. Avogadri, F., Martinoli, C., Petrovska, L., Chiodoni, C., Transidico, P., Bronte, V., Longhi, R., Colombo, M.P., Dougan, G., Rescigno, M., (2005). Cancer immunotherapy based on killing of Salmonella-infected tumor cells. Cancer Res 65, 3920-3927.
5. Avogadri, F., Martinoli, C., Petrovska, L., et al. (2005) Cancer immunotherapy based on killing of Salmonella-infected tumor cells. Cancer Res. 65, 3920-3927.
6. Barak, Y., Schreiber, F., Thorne, S.H., Contag, C.H., Debeer, D., Matin, (2011). A., Role of nitric oxide in Salmonella typhimurium-mediated cancer cell killing. BMC Cancer 10, 146.
7. Barak, Y., Thorne, S. H., Ackerley, D. F., Lynch, S. V., Contag, C. H., and Matin, A. (2006) New enzyme for reductive cancer chemotherapy, YieF, and its improvement by directed evolution. Mol. Cancer Ther. 5, 97-103.
8. Barbe S, Van Mellaert L, Anne J (2006) The use of clostridial spores for cancer treatment. J Appl Microbiol 101:571-578.
9. Basu D, Herlyn M. (2008). Salmonella typhimurium as a novel RNA interference vector for cancer gene therapy, Cancer Biology & Therapy, 7: 1-2.
10. Bauer H, Darji A, Chakraborty T, Weiss S. (2005). Salmonella-mediated oral DNA vaccination using stabilized eukaryotic expression plasmids. Gene Ther, 12:364-72.
11. Bereta, M., Hayhurst, A., Gajda, M., Chorobik, P., Targosz, M., Marcinkiewicz, J., Kaufman, H.L., (2007). Improving tumor targeting and therapeutic potential of Salmonella VNP20009 by displaying cell surface CEA-specific antibodies. Vaccine 25, 4183-4192.
12. Bermudes D, Zheng L, King IC. (2002) Live bacteria as anticancer agents and tumor-selective protein delivery vectors. Curr Opin Drug Discov Devel, 5(2):194-199.
13. Bettegowda C, Dang LH, Abrams R, Huso DL, Dillehay L, Cheong I, Agrawal N, Borzillary S, McCaffery JM, Watson EL et al (2003) Overcoming the hypoxic barrier to radiation therapy with anaerobic bacteria. Proc Natl Acad Sci U S A 100:15083-15088.
14. Cao, H.D., Yang, Y.X., Lu, L., Liu, S.N., Wang, P.L., Tao, X.H., Wang, L.J., Xiang, T.X., (2010). Attenuated Salmonella typhimurium carrying TRAIL and VP3 genes inhibits the growth of gastric cancer cells in vitro and in vivo. Tumori 96, 296-303.
15. Carey R, Holland J, Whang H, Neter E, Bryant B. (1967). Clostridial oncolysis in man. Eur J Cancer, 3:37-46.
16. Chanana, V., Majumdar, S., Rishi, P., (2007). Involvement of caspase-3, lipid peroxidation and TNF-alpha in causing apoptosis of macrophages by coordinately expressed Salmonella phenotype under stress conditions. Mol Immunol 44, 1551-1558.
17. Chander, H., Majumdar, S., Sapru, S., Rishi, P., (2006). 55 kDa outer-membrane protein from short-chain fatty acids exposed Salmonella enterica serovar Typhi induces apoptosis in macrophages. Antonie Van Leeuwenhoek 89, 317-323.
18. Chou, C.K., Hung, J.Y., Liu, J.C., Chen, C.T., Hung, M.C., (2006). An attenuated Salmonella oral DNA vaccine prevents the growth of hepatocellular carcinoma and colon cancer that express alpha-fetoprotein. Cancer Gene Ther 13, 746-752.
19. Coley WB. (1991) The treatment of malignant tumors by repeated inoculations of erysipelas. With a report of ten original cases. 1893. Clin Orthop Relat Res 3-11.
20. Dang LH, Bettegowda C, Huso DL, Kinzler KW, Vogelstein B (2001) Combination bacteriolytic therapy for the treatment of experimental tumors. Proc Natl Acad Sci U S A 98:15155-15160.
21. Eisenstark A, Kazmierczak RA, Dino A, Khreis R, Newman D, Schatten H. (2006). Development of Salmonella Strains as Cancer Therapy Agents and Testing in Tumor Cell Lines. Methods in Molecular Biology, vol. 394: Salmonella: Methods and Protocols Edited by: H. Schatten and A. Eisenstark., Humana Press Inc., Totowa, NJ.
22. Fensterle J, Bergmann B, Yone CL, Hotz C, Meyer SR, Spreng S, Goebel W, Rapp UR, Gentschev I. (2008). Cancer immunotherapy based on recombinant Salmonella enterica serovar Typhimurium aroA strains secreting prostate-specific antigen and cholera toxin subunit B. Cancer Gene Ther, 15:85-93.
23. Folkman J (2006) Antiangiogenesis in cancer therapy- endostatin and its mechanisms of action. Exp Cell Res 312:594-607.
24. Fraillery, D., Baud, D., Pang, S.Y., Schiller, J., Bobst, M., Zosso, N., Ponci, F., Nardelli-Haefliger, D., (2007). Salmonella enterica serovar Typhi Ty21a expressing human papillomavirus type 16 L1 as a potential live vaccine against cervical cancer and typhoid fever. Clin Vaccine Immunol 14, 1285-1295.
25. Fu, W., Lan, H., Li, S., Han, X., Gao, T., Ren, D., (2008). Synergistic antitumor efficacy of suicide/ePNP gene and 6-methylpurine 2'-deoxyriboside via Salmonella against murine tumors. Cancer Gene Ther 15, 474-484.
26. Galan JE (2001) Salmonella interactions with host cells: type III secretion at work. Annu Rev Cell Dev Biol 17:53-86.
27. Ganai, S., Arenas, R.B., Forbes, N.S., (2009). Tumour-targeted delivery of TRAIL using Salmonella typhimurium enhances breast cancer survival in mice. Br J Cancer 101, 1683-1691.
28. Guiney DG. (2005). The Role of Host Cell Death in Salmonella Infections. CTMI, 289:131-150.
29. Guo, C. C., Ding, J., Pan, B. R., et al. (2003) Development of an oral DNA vaccine against MG7-Ag of gastric cancer using attenuated salmonella typhimurium as carrier. World J. Gastroenterol. 9, 1191-1195.
30. Hidaka A, Hamaji Y, Sasaki T, Taniguchi S, Fujimori M (2007) Exogenous cytosine deaminase gene expression in Bifidobacterium breve I-53-8w for tumor-targeting enzyme/prodrug therapy. Biosci Biotechnol Biochem 71:2921-2926.
31. Holden DW (2002) Trafficking of the Salmonella vacuole in macrophages. Traffic 3:161-169.
32. Jia, L. J., Xu, H. M., Ma, D. Y., et al. (2005) Enhanced therapeutic effect by combination of tumor-targeting Salmonella and endostatin in murine melanoma model. Cancer Biol. Ther. 4.
33. Kasinskas RW, Forbes NS (2006) Salmonella typhimurium specifically chemotax and proliferate in heterogeneous tumor tissue in vitro. Biotechnol Bioeng 94:710-721.
34. Kasinskas RW, Forbes NS (2007) Salmonella typhimurium lacking ribose chemoreceptors localize in tumor quiescence and induce apoptosis. Cancer Res 67:3201-3209.
35. Knodler LA, Steele-Mortimer O (2003) Taking possession: biogenesis of the Salmonella-containing vacuole. Traffic 4:587-599.
36. Lee, C.H., Wu, C.L., Tai, Y.S., Shiau, A.L., (2005). Systemic administration of attenuated Salmonella choleraesuis in combination with cisplatin for cancer therapy. Mol Ther 11, 707-716.
37. Leschner S, Weiss S. (2010). Salmonella-allies in the fight against cancer. J Mol Med, 88:763-773.
38. Leschner S, Westphal K, Dietrich N, Viegas N, Jablonska J, Lyszkiewicz M, Lienenklaus S, Falk W, Gekara N, Loessner H et al (2009) Tumor invasion of Salmonella enterica serovar Typhimurium is accompanied by strong hemorrhage promoted by TNFalpha. PLoS One 4:e6692.
39. Li, Y. H., Xie, Y. M., Guo, K. Y., et al. (2001) Treatment of tumor in mice by oral administration of cytosine deaminase gene carried in live attenuated Salmonella. Acta Biochimica et Biophysica Sinica (ABBS): 33, 233-237.
40. Loeffler M, Le'Negrate G, Krajewska M, Reed JC. (2007). Attenuated Salmonella engineered to produce human cytokine LIGHT inhibit tumor growth. Proc Natl Acad Sci U S A. 104:12879-83.
41. Loeffler, M., Le'Negrate, G., Krajewska, M., Reed, J.C., (2008). Inhibition of tumor growth using salmonella expressing Fas ligand. J Natl Cancer Inst 100, 1113-1116.
42. Loeffler, M., Le'Negrate, G., Krajewska, M., Reed, J.C., (2009). Salmonella typhimurium engineered to produce CCL21 inhibit tumor growth. Cancer Immunol Immunother 58, 769-775.
43. Low KB, Ittensohn M, Lin S, Clairmont C, Luo X, Zheng L-M, King I, Pawelek JM. (1999). VNP20009, a genetically modified Salmonella typhimurium for treatment of solid tumors. Proc Am Assoc Cancer Res, 40:851.
44. Luo X, Ittensohn M, Low B, Pawelek J, Li Z, Ma X, Bermudes D. (1999). Genetically modified Salmonella typhimurium inhibited growth of primary tumors and metastase. Proc Annu Meet Am Assoc Cancer Res, 40:3146.
45. Majno G, Joris I (1995) Apoptosis, oncosis, and necrosis. An overview of cell death. Am J Pathol 146:3-15.
46. Malmgren RA, Flanigan CC. (1955). Localization of the vegetative form of Clostridium tetani in mouse tumors following intravenous spore administration. Cancer Res, 15:473-478.
47. Marsden VS et al. (2002) Apoptosis initiated by Bcl-2-regulated caspase activation independently of the cytochrome c/Apaf-1/caspase-9 apoptosome. Nature 419:634-637.
48. McClellan, M., Benner, J., Schilsky, R., Epstein, D., Woosley, R., Friend, S., Sidransky, D., Geoghegan, C., Kessler, D., (2011). An accelerated pathway for targeted cancer therapies. Nat Rev Drug Discov 10, 79-80.
49. Mei, S., Theys, J., Landuyt, W., Anne, J., and Lambin, P. (2002) Optimization of tumor-targeted gene delivery by engineered attenuated Salmonella typhimurium. Anticancer Res. 22, 3261-3266.
50. Minton NP: Clostridia in cancer therapy. 2003. Nat Rev Microbiol, 1:237-242.
51. Moreno, M., Kramer, M.G., Yim, L., Chabalgoity, J.A., (2010). Salmonella as live trojan horse for vaccine development and cancer gene therapy. Curr Gene Ther 10, 56-76.
52. Murray, S. R., de Felipe, K. S., Obuchowski, P. L., Pike, J., Bermudes, D., and Low, K. B. (2004) Hot spot for a large deletion in the 18-to 19-centisome region confers a multiple phenotype in Salmonella enterica serovar Typhimurium strain ATCC 14028. J. Bacteriol. 186, 8516-8523.
53. Nagakura, C., Hayashi, K., Zhao, M., Yamauchi, K., Yamamoto, N., Tsuchiya, H., Tomita, K., Bouvet, M., Hoffman, R.M., (2009). Efficacy of a genetically-modified Salmonella typhimurium in an orthotopic human pancreatic cancer in nude mice. Anticancer Res 29, 1873-1878.
54. Nemunaitis J, Cunningham C, Senzer N, Kuhn J, Cramm J, Litz C, Cavagnolo R, Cahill A, Clairmont C, Sznol M. (2003). Pilot trial of genetically modified, attenuated Salmonella expressing the E. coli cytosine deaminase gene in refractory cancer patients. Cancer Gene Ther; 10:737-44.
55. Nemunaitis, J., Cunningham, C., Senzer, N. (2003) Pilot trial of genetically modified, attenuated Salmonella expressing the E. coli cytosine deaminase gene in refractory cancer patients. Cancer Gene. Ther. 10, 737-744.
56. Nguyen, V.H., Kim, H.S., Ha, J.M., Hong, Y., Choy, H.E., Min, J.J., (2009). Genetically engineered Salmonella typhimurium as an imageable therapeutic probe for cancer. Cancer Res 70, 18-23.
57. Ohl ME, Miller SI (2001) Salmonella: a model for bacterial pathogenesis. Annu Rev Med 52:259-274.
58. Paesold, G., Guiney, D.G., Eckmann, L., Kagnoff, M.F., (2002). Genes in the Salmonella pathogenicity island 2 and the Salmonella virulence plasmid are essential for Salmonella-induced apoptosis in intestinal epithelial cells. Cell Microbiol 4, 771-781.
59. Paterson, Y., Guirnalda, P.D., Wood, L.M., (2010). Listeria and Salmonella bacterial vectors of tumor-associated antigens for cancer immunotherapy. Semin Immunol 22, 183-189.
60. Pawelek JM, Low KB, Bermudes D (1997) Tumor-targeted Salmonella as a novel anticancer vector. Cancer Res 57:4537-4544.
61. Pawelek JM, Low KB, Bermudes D (2003) Bacteria as tumourtargeting vectors. Lancet Oncol 4:548-556.
62. Porwollik, S., Wong, R. M., Helm, R. A., et al. (2004) DNA amplification and rearrangements in archival Salmonella enterica serovar Typhimurium LT2 cultures. J. Bacteriol. 186, 1678-1682.
63. Roider, E., Jellbauer, S., Kohn, B., Berchtold, C., Partilla, M., Busch, D.H., Russmann, H., Panthel, K., Invasion and destruction of a murine fibrosarcoma by Salmonella-induced effector CD8 T cells as a therapeutic intervention against cancer. Cancer Immunol Immunother 60, 371-380.
64. Ryan, R.M., Green, J., Williams, P.J., Tazzyman, S., Hunt, S., Harmey, J.H., Kehoe, S.C., Lewis, C.E., (2009). Bacterial delivery of a novel cytolysin to hypoxic areas of solid tumors. Gene Ther 16, 329-339.
65. Saccheri, F., Pozzi, C., Avogadri, F., Barozzi, S., Faretta, M., Fusi, P., Rescigno, M., (2011). Bacteria-induced gap junctions in tumors favor antigen cross-presentation and antitumor immunity. Sci Transl Med 2, 44ra57.
66. Santos RL, Zhang S, Tsolis RM, Kingsley RA, Adams LG, Baumler AJ (2001) Animal models of Salmonella infections: enteritis versus typhoid fever. Microbes Infect 3:1335-1344.
67. Shahabi, V., Maciag, P.C., Rivera, S., Wallecha, A., (2010). Live, attenuated strains of Listeria and Salmonella as vaccine vectors in cancer treatment. Bioeng Bugs 1, 235-239.
68. Sorenson, B.S., Banton, K.L., Frykman, N.L., Leonard, A.S., Saltzman, D.A., (2008). Attenuated Salmonella typhimurium with interleukin 2 gene prevents the establishment of pulmonary metastases in a model of osteosarcoma. J Pediatr Surg 43, 1153-1158.
69. Stritzker J, Weibel S, Hill PJ, Oelschlaeger TA, Goebel W, Szalay AA (2007) Tumor-specific colonization, tissue distribution, and gene induction by probiotic Escherichia coli Nissle 1917 in live mice. Int J Med Microbiol 297:151-162.
70. Takaya, A., Suzuki, A., Kikuchi, Y., Eguchi, M., Isogai, E., Tomoyasu, T., Yamamoto, T., (2005). Derepression of Salmonella pathogenicity island 1 genes within macrophages leads to rapid apoptosis via caspase-1-and caspase-3-dependent pathways. Cell Microbiol 7, 79-90.
71. Theys J, Barbe S, Landuyt W, Nuyts S, Van Mellaert L, Wouters B, Anne J, Lambin P. (2003) Tumor-specific gene delivery using genetically engineered bacteria. Curr Gene Ther 3:207-221.
72. Thomas-Tikhonenko A, Hunter CA. (2003). Infection and cancer: the common vein. Cytokine Growth Factor Rev; 14:67-77.
73. Van Mellaert L, Barbe S, Anne J (2006) Clostridium spores as anti-tumour agents. Trends Microbiol 14:190-196.
74. Vazquez-Torres A et al. (1999) Extraintestinal dissemination of Salmonella by CD18-expressing phagocytes. Nature 401:804-808.
75. Vendrell, A., Gravisaco, M.J., Pasetti, M.F., Croci, M., Colombo, L., Rodriguez, C., Mongini, C., Waldner, C.I., (2010). A novel Salmonella Typhi-based immunotherapy promotes tumor killing via an antitumor Th1-type cellular immune response and neutrophil activation in a mouse model of breast cancer. Vaccine 29, 728-736.
76. Vendrell, A., Gravisaco, M.J., Pasetti, M.F., Croci, M., Colombo, L., Rodriguez, C., Mongini, C., Waldner, C.I., (2010). A novel Salmonella Typhi-based immunotherapy promotes tumor killing via an antitumor Th1-type cellular immune response and neutrophil activation in a mouse model of breast cancer. Vaccine 29, 728-736.
77. Weinrauch Y, Zychlinsky A (1999) The induction of apoptosis by bacterial pathogens. Annu Rev Microbiol 53:155-187.
78. Xiang S, Fruehauf J, Li CJ (2006) Short hairpin RNA-expressing bacteria elicit RNA interference in mammals. Nat Biotechnol 24:697-702.
79. Xiong, G., Husseiny, M.I., Song, L., Erdreich-Epstein, A., Shackleford, G.M., Seeger, R.C., Jackel, D., Hensel, M., Metelitsa, L.S., (2010). Novel cancer vaccine based on genes of Salmonella pathogenicity island 2. Int J Cancer 126, 2622-2634.
80. Yam C, Zhao M, Hayashi K, Ma H, Kishimoto H, McElroy M, Bouvet M, Hoffman RM (2009) Monotherapy with a tumortargeting mutant of S. Typhimurium Inhibits Liver Metastasis in a Mouse Model of Pancreatic Cancer. J Surg Res.
81. Yang, N., Zhu, X., Chen, L., Li, S., Ren, D., (2008). Oral administration of attenuated S. Typhimurium carrying shRNA-expressing vectors as a cancer therapeutic. Cancer Biol Ther 7, 145-151.
82. Yoon WS, Choi WC, Sin JI, Park YK. (2007). Antitumor therapeutic effects of Salmonella typhimurium containing Flt3 Ligand expression plasmids in melanoma-bearing mouse. Biotechnol Lett 29:511-6.
83. Yoon, W.S., Chae, Y.S., Hong, J., Park, Y.K., (2011). Antitumor therapeutic effects of a genetically engineered Salmonella typhimurium harboring TNF-alpha in mice. Appl Microbiol Biotechnol 89, 1807-1819.
84. Yu YA, Shabahang S, Timiryasova TM, Zhang Q, Beltz R, Gentschev I, Goebel W, Szalay AA (2004) Visualization of tumors and metastases in live animals with bacteria and vaccinia virus encoding light-emitting proteins. Nat Biotechnol 22:313-320.
85. Yu YA, Zhang Q, Szalay AA (2008) Establishment and characterization of conditions required for tumor colonization by intravenously delivered bacteria. Biotechnol Bioeng 100:567-578.
86. Yuhua L, KunYaun G, Hui C, Yongmei X, Chayonag S, Xun T, Daming R. (2001). Oral cytokine gene therapy against murine tumors using attenuated salmonella Typhimurium. Int. J. Cancer: 94, 438-443.
87. Zhang, L., Gao, L., Zhao, L., Guo, B., Ji, K., Tian, Y., Wang, J., Yu, H., Hu, J., Kalvakolanu, D.V., Kopecko, D.J., Zhao, X., Xu, D.Q., (2007). Intratumoral delivery and suppression of prostate tumor growth by attenuated Salmonella enteric serovar typhimurium carrying plasmid-based small interfering RNAs. Cancer Res 67, 5859-5864.
88. Zhao M, Geller J, Ma H, Yang M, Penman S, Hoffman RM. (2007). Monotherapy with a tumortargeting mutant of Salmonella typhimurium cures orthotopic metastatic mouse models of human prostate cancer. Proc Natl Acad Sci USA; 104:10170-4.
89. Zhao, M., Yang, M., Li, X. M., et al. (2005) Tumor-targeting bacterial therapy with amino acid auxotrophs of GFP-expressing Salmonella typhimurium. Proc. Natl. Acad. Sci. USA 102, 755-760.
90. Zhu, X., Cai, J., Huang, J., Jiang, X., Ren, D., (2010). The treatment and prevention of mouse melanoma with an oral DNA vaccine carried by attenuated Salmonella typhimurium. J Immunother 33, 453-460.